Mild OSA – medical trial — RACP Paediatrics MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Intranasal corticosteroids
For mild OSA, a trial of intranasal corticosteroids (mometasone or fluticasone) for 6-12 weeks may reduce adenoidal size and improve OSA. Montelukast is sometimes added. If symptoms persist or worsen, adenotonsillectomy should be reconsidered. A repeat sleep study after medical therapy guides further management.
Reference: RCH Melbourne – 2023 – OSA CPG; RACP Paediatric Curriculum – Respiratory